Japan, May 18 -- NOVARTIS AG has got intellectual property rights for 'METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES.' Other related details are as follows:

Application Number: JP,2024-091065

Category (FI): C07K16/36,A61P9/00,A61K39/395@N,A61P9/10,A61P7/02,A61P13/12

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 5, 2024

Publication Date: Aug. 27, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....